Neurent Medical closes €62.5m oversubscribed Series C financing round
Apr 18, 2026
Neurent Medical has closed an oversubscribed €62.5 million Series C financing round for its Neuromark device for chronic rhinitis. The funding will support commercial expansion, broader evidence generation and pipeline development.